Trailblazer Merger Corp I: Nasdaq/NYSE listing notice — Trailblazer Merger I receives Nasdaq deficiency notices for MVPHS and PHS below minimum thresholds

Trailblazer Merger Corp I

MVPHS below $15M for 30 consecutive business days; 180-day cure period ends Aug 31, 2026.
PHS below 1,100,000; must submit compliance plan within 45 days, possible 180-day extension.
Company expects to cure deficiencies via its pending business combination with Cyabra Strategy Ltd.
Failure to regain compliance could lead to delisting or transfer to Nasdaq Capital Market.
No immediate effect on trading; TBMC and TBMCR continue to trade on Nasdaq Global Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Trailblazer Merger Corp I received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(D)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(C), 5810(c)(3)(D)

Exact text from the filing

March 3, 2026,Trailblazer Merger Corporation I (the “ Company ”) received a letter from Nasdaq (the “ Notice ”) which notified the Company that, for 30 consecutive business days, the Company’s market value of publicly held shares (“ MVPHS ”) was below the $15,000,000 threshold required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(C) (the “ MVPHS Rule ”). In accordance with Nasdaq Listing Rule 5810(c)(3)(D), the Company has 180 calendar days, or until August 31, 2026 (the “ MVPHS Compliance Period ”), to regain compliance with the MVPHS Rule. The Notice

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-26-025191

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.